BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 28473880)

  • 1. New approaches to combat
    Gerits E; Verstraeten N; Michiels J
    J Oral Microbiol; 2017; 9(1):1300366. PubMed ID: 28473880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the HUβ Protein Prevents Porphyromonas gingivalis from Entering into Preexisting Biofilms.
    Rocco CJ; Bakaletz LO; Goodman SD
    J Bacteriol; 2018 Jun; 200(11):. PubMed ID: 29437850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Resveratrol on biofilm formation and virulence factor gene expression of Porphyromonas gingivalis in periodontal disease.
    Kugaji MS; Kumbar VM; Peram MR; Patil S; Bhat KG; Diwan PV
    APMIS; 2019 Apr; 127(4):187-195. PubMed ID: 30861212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative proteomic analysis of extracellular matrix extracted from mono- and dual-species biofilms of Fusobacterium nucleatum and Porphyromonas gingivalis.
    Mohammed MMA; Pettersen VK; Nerland AH; Wiker HG; Bakken V
    Anaerobe; 2017 Apr; 44():133-142. PubMed ID: 28285095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin Receptor Agonists as the "Perioceutics" Agents for Periodontal Disease through Modulation of Porphyromonas gingivalis Virulence and Inflammatory Response.
    Zhou W; Zhang X; Zhu CL; He ZY; Liang JP; Song ZC
    PLoS One; 2016; 11(11):e0166442. PubMed ID: 27832188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural antigenic differences in the functionally equivalent extracellular DNABII proteins of bacterial biofilms provide a means for targeted biofilm therapeutics.
    Rocco CJ; Davey ME; Bakaletz LO; Goodman SD
    Mol Oral Microbiol; 2017 Apr; 32(2):118-130. PubMed ID: 26988714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual lifestyle of Porphyromonas gingivalis in biofilm and gingival cells.
    Sakanaka A; Takeuchi H; Kuboniwa M; Amano A
    Microb Pathog; 2016 May; 94():42-7. PubMed ID: 26456558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of d-valine on periodontal or peri-implant pathogens: Porphyromonas gingivalis biofilm.
    Qi H; Li B; Wang H; Cai Q; Quan X; Cui Y; Meng W
    J Periodontol; 2018 Mar; 89(3):303-314. PubMed ID: 29520781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activity of bacterial peptidylarginine deiminase is important during formation of dual-species biofilm by periodontal pathogen Porphyromonas gingivalis and opportunistic fungus Candida albicans.
    Karkowska-Kuleta J; Bartnicka D; Zawrotniak M; Zielinska G; Kieronska A; Bochenska O; Ciaston I; Koziel J; Potempa J; Baster Z; Rajfur Z; Rapala-Kozik M
    Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29668945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the tea catechin epigallocatechin gallate on Porphyromonas gingivalis biofilms.
    Asahi Y; Noiri Y; Miura J; Maezono H; Yamaguchi M; Yamamoto R; Azakami H; Hayashi M; Ebisu S
    J Appl Microbiol; 2014 May; 116(5):1164-71. PubMed ID: 24471579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas aeruginosa biofilm infections: from molecular biofilm biology to new treatment possibilities.
    Tolker-Nielsen T
    APMIS Suppl; 2014 Dec; (138):1-51. PubMed ID: 25399808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of N-acyl homoserine lactone analogues on Porphyromonas gingivalis biofilm formation.
    Asahi Y; Noiri Y; Igarashi J; Asai H; Suga H; Ebisu S
    J Periodontal Res; 2010 Apr; 45(2):255-61. PubMed ID: 19778324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAR-encapsulated nanoparticles for the inhibition and disruption of Porphyromonas gingivalis-Streptococcus gordonii biofilms.
    Mahmoud MY; Demuth DR; Steinbach-Rankins JM
    J Nanobiotechnology; 2018 Sep; 16(1):69. PubMed ID: 30219060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porphyromonas gingivalis: An Overview of Periodontopathic Pathogen below the Gum Line.
    How KY; Song KP; Chan KG
    Front Microbiol; 2016; 7():53. PubMed ID: 26903954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community Development between
    Sztukowska MN; Dutton LC; Delaney C; Ramsdale M; Ramage G; Jenkinson HF; Nobbs AH; Lamont RJ
    mBio; 2018 Apr; 9(2):. PubMed ID: 29691333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide-Based Inhibitors of Fimbrial Biogenesis in Porphyromonas gingivalis.
    Alaei SR; Park JH; Walker SG; Thanassi DG
    Infect Immun; 2019 Mar; 87(3):. PubMed ID: 30642895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of polysaccharide synthesis by the sinR orthologue PGN_0088 is indirectly associated with the penetration of Porphyromonas gingivalis biofilms by macrolide antibiotics.
    Yamamoto R; Noiri Y; Yamaguchi M; Asahi Y; Maezono H; Ebisu S; Hayashi M
    Microbiology (Reading); 2015 Feb; 161(Pt 2):422-429. PubMed ID: 25500494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Susceptibility of porphyromonas gingivalis to metronidazole at different planktonic cell densities and in biofilm].
    Duan D; Wang S; Zhang L; Zhao L; Xu Y
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2011 Dec; 29(6):571-5. PubMed ID: 22332564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraspecies Variability Affects Heterotypic Biofilms of Porphyromonas gingivalis and Prevotella intermedia: Evidences of Strain-Dependence Biofilm Modulation by Physical Contact and by Released Soluble Factors.
    Barbosa GM; Colombo AV; Rodrigues PH; Simionato MR
    PLoS One; 2015; 10(9):e0138687. PubMed ID: 26406499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spheres of influence: Porphyromonas gingivalis outer membrane vesicles.
    Gui MJ; Dashper SG; Slakeski N; Chen YY; Reynolds EC
    Mol Oral Microbiol; 2016 Oct; 31(5):365-78. PubMed ID: 26466922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.